Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renzo Galanello

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Clinical Chemistry and Laboratory Medicine|August 14, 2010
ThalassoChip, an array mutation and single nucleotide polymorphism detection tool for the diagnosis of β-thalassaemiaChristos Shammas, Thessalia Papasavva, Xenia Felekis, et al.
Human Molecular Genetics|May 8, 2009
Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemiaSerena Sanna, Fabio Busonero, Andrea Maschio, et al.
Haematologica|December 7, 2014
A genetic score for the prediction of beta-thalassemia severityFabrice Danjou, Marcella Francavilla, Franco Anni, et al.
Circulation|March 30, 2011
On T2* magnetic resonance and cardiac ironJohn-Paul Carpenter, Taigang He, Paul Kirk, et al.
Nature Genetics|September 15, 2015
Genome-wide association analyses based on whole-genome sequencing in Sardinia provide insights into regulation of hemoglobin levelsFabrice Danjou, Magdalena Zoledziewska, Carlo Sidore, et al.
Haematologica|September 20, 2015
Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disordersLouise de Swart, Jan C M Hendriks, Lisa N van der Vorm, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 3, 2010
International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centersPaul Kirk, Taigang He, Lisa J Anderson, et al.
Blood|December 15, 2005
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemiaMaria Domenica Cappellini, Alan Cohen, Antonio Piga, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2008
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemiaManuela Uda, Renzo Galanello, Serena Sanna, et al.
European Journal of Haematology|November 22, 2007
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective studyJohn Porter, Renzo Galanello, Giuseppe Saglio, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Clinical Chemistry and Laboratory Medicine|August 14, 2010
ThalassoChip, an array mutation and single nucleotide polymorphism detection tool for the diagnosis of β-thalassaemiaChristos Shammas, Thessalia Papasavva, Xenia Felekis, et al.
Human Molecular Genetics|May 8, 2009
Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemiaSerena Sanna, Fabio Busonero, Andrea Maschio, et al.
Haematologica|December 7, 2014
A genetic score for the prediction of beta-thalassemia severityFabrice Danjou, Marcella Francavilla, Franco Anni, et al.
Circulation|March 30, 2011
On T2* magnetic resonance and cardiac ironJohn-Paul Carpenter, Taigang He, Paul Kirk, et al.
Nature Genetics|September 15, 2015
Genome-wide association analyses based on whole-genome sequencing in Sardinia provide insights into regulation of hemoglobin levelsFabrice Danjou, Magdalena Zoledziewska, Carlo Sidore, et al.
Haematologica|September 20, 2015
Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disordersLouise de Swart, Jan C M Hendriks, Lisa N van der Vorm, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 3, 2010
International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centersPaul Kirk, Taigang He, Lisa J Anderson, et al.
Blood|December 15, 2005
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemiaMaria Domenica Cappellini, Alan Cohen, Antonio Piga, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2008
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemiaManuela Uda, Renzo Galanello, Serena Sanna, et al.
European Journal of Haematology|November 22, 2007
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective studyJohn Porter, Renzo Galanello, Giuseppe Saglio, et al.
Pageof 12